Post-ischemic administration of pravastatin reduces neuronal injury by inhibiting Bax protein expression after transient forebrain ischemia in rats

Neuroscience Letters

Volumn 594, Issue , 2015, Pages 87-92

  Jung, Yoo Sun ^a   Oh, Ah Young ^b   Park, Hee Pyoung ^a   Hwang, Jung Won ^b   Lim, Young Jin ^a   Jeon, Young Tae ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Apoptosis; Bax protein; Brain ischemia; Pravastatin

Indexed keywords

DRUG THERAPY; NEUROPROTECTIVE AGENT; PHARMACOLOGY; PRAVASTATIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL GAS; ARTICLE; BLOOD GAS ANALYSIS; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECTS; DRUG THERAPY; FOREBRAIN; HIPPOCAMPAL CA1 REGION; HYPOTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; METABOLISM; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CA1 REGION, HIPPOCAMPAL; DRUG EFFECTS; DRUG THERAPY; ISCHEMIC ATTACK, TRANSIENT; MALE; METABOLISM; NEURONS; NEUROPROTECTIVE AGENTS; PATHOLOGY; PHARMACOLOGY; PRAVASTATIN; PROSENCEPHALON; RATS, SPRAGUE-DAWLEY; THERAPEUTIC USE;

EID: 84964203357     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.03.038     Document Type: Article

References (29)

1. Baughman V.L., Hoffman W.E., Miletich D.J., Albrecht R.F., Thomas C. Neurologic outcome in rats following incomplete cerebral ischemia during halothane, isoflurane, or N2O. Anesthesiology 1988, 69:192-198.
2. Berger C., Xia F., Maurer M.H., Schwab S. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res. Rev. 2008, 58:48-56.
3. Broughton B.R., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:e331-339.
4. Cheng G., Wei L., Zhi-dan S., Shi-guang Z., Xiang-zhen L. Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway. BMC Neurosci. 2009, 10:7.
5. Daimon M., Aomi S., Kawamata T., Kurosawa H. Pravastatin a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor reduces delayed neuronal death following transient forebrain ischemia in the adult rat hippocampus. Neurosci. Lett. 2004, 362:122-126.
6. Engelhard K., Werner C., Eberspächer E., Pape M., Stegemann U., Kellermann K., Hollweck R., Hutzler P., Kochs E. Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation. Anesthesiology 2004, 101:912-917.
7. Franke C., Nöldner M., Abdel-Kader R., Johnson-Anuna L.N., Wood W.G., Muller W.E., Eckert G.P. Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiol. Dis. 2007, 25:438-445.
8. Hara A., Iwai T., Niwa M., Uematsu T., Yoshimi N., Tanaka T., Mori H. Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res. 1996, 711:249-253.
9. Harukuni I., Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol. Clin. 2006, 24:1-21.
10. Howard R.S., Holmes P.A., Koutroumanidis M.A. Hypoxic-ischaemic brain injury. Pract. Neurol. 2011, 11:4-18.
11. Istvan E.S., Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001, 292:1160-1164.
12. Jeon Y., Hwang J., Lim Y., Kim A., Park H. A combination of sevoflurane postconditioning and albumin increases Bcl-2 expression after transient global cerebral ischemia compared with either sevoflurane postconditioning or albumin alone. J. Neurosurg. Anesthesiol. 2013, 25:43-50.
13. Johnson-Anuna L.N., Eckert G.P., Keller J.H., Igbavboa U., Franke C., Fechner T., Schubert-Zsilavecz M., Karas M., Müller W.E., Wood W.G. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J. Pharmacol. Exp. Ther. 2005, 312:786-793.
14. Kersten J.R., Fleisher L.A. Statins: the next advance in cardioprotection?. Anesthesiology 2006, 105:1079-1080.
15. Kimbro J.R., Kelly P.J., Drummond J.C., Cole D.J., Patel P.M. Isoflurane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex. Anesthesiology 2000, 92:806-812.
16. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., Oltvai Z.N. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 1993, 4:327-332.
17. Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D.J., Sessa W.C., Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med. 2000, 6:1004-1010.
18. Laufs U., Gertz K., Dirnagl U., Böhm M., Nickenig G., Endres M. Rosuvastatin a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res. 2002, 942:23-30.
19. Liao J.K. Isoprenoids as mediators of the biological effects of statins. J. Clin. Invest. 2002, 110:285-288.
20. Mao X., Ji C., Sun C., Cao D., Ma P., Ji Z., Cao F., Min D., Li S., Cai J. Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis. Neurochem. Int. 2012, 60:39-46.
21. Mariucci G., Taha E., Tantucci M., Spaccatini C., Tozzi A., Ambrosini M.V. Intravenous administration of pravastatin immediately after middle cerebral artery occlusion reduces cerebral oedema in spontaneously hypertensive rats. Eur. J. Pharmacol. 2011, 660:381-386.
22. Pape M., Engelhard K., Eberspächer E., Hollweck R., Kellermann K., Zintner S., Hutzler P., Werner C. The long-term effect of sevoflurane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth. Analg. 2006, 103:173-179.
23. Prinz V., Laufs U., Gertz K., Kronenberg G., Balkaya M., Leithner C., Lindauer U., Endres M. Intravenous rosuvastatin for acute stroke treatment an animal study. Stroke 2008, 39:433-438.
24. Razavi H.M., Hamilton J.A., Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol. Therapeut. 2005, 106:147-162.
25. Schneider A., Böttiger B.W., Popp E. Cerebral resuscitation after cardiocirculatory arrest. Anesth. Analg. 2009, 108:971-979.
26. Seo J., Park H., Jeon Y., Lim Y., Nam K., Hwang J. Combined treatment with celecoxib and sevoflurane after global cerebral ischaemia has no additive neuroprotective effects in rats. Br. J. Anaesth. 2013, 110:988-995.
27. Sironi L., Cimino M., Guerrini U., Calvio A.M., Lodetti B., Asdente M., Balduini W., Paoletti R., Tremoli E. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler. Thromb. Vasc. Biol. 2003, 23:322-327.
28. Sugiura S., Yagita Y., Sasaki T., Todo K., Terasaki Y., Ohyama N., Hori M., Kitagawa K. Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion. Brain Res. 2007, 1181:125-129.
29. Vaughan C.J., Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999, 30:1969-1973.